Claritev Corporation (CTEV) is a publicly traded Healthcare sector company. As of July 9, 2026, CTEV trades at $32.51 with a market cap of $539.05M and a P/E ratio of -1.89. CTEV moved +1.91% today. Year to date, CTEV is -25.10%; over the trailing twelve months it is -35.40%. Its 52-week range spans $11.50 to $74.07. Analyst consensus is strong buy with an average price target of $39.80. Rallies surfaces CTEV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for CTEV shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $32.51 |
| Market Cap | $539.05M |
| P/E Ratio | -1.89 |
| EPS | $-17.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $74.07 |
| 52-Week Low | $11.50 |
| Volume | 41.96K |
| Avg Volume | 0 |
| Revenue (TTM) | $965.41M |
| Net Income | $-284.28M |
| Gross Margin | 0.00% |
5 analysts cover CTEV: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $39.80.